Page last updated: 2024-09-03

mk 0663 and Gout

mk 0663 has been researched along with Gout in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Li, M; Yu, C; Zeng, X1
Hu, SX; Lei, XM; Shen, GF; Ye, C; Yu, F; Yu, YK; Zhang, ST1
Liu, P; Ma, JL; Wang, J; Zhang, S; Zhang, W; Zhang, Y1
Norquist, JM; Schlesinger, N; Watson, DJ1
Cochrane, DJ; Jarvis, B; Keating, GM1
Antigua, J; Burton, R; Chen, E; Geba, GP; Londoño, J; Lund, M; Najarian, DK; Navarra, S; Ozturk, ZE; Petruschke, RA; Pryhuber, KG; Rubin, BR1
Krüger, K1
Navarra, S; Rubin, BR; Smugar, SS; Tershakovec, AM; Yu, Q1

Reviews

4 review(s) available for mk 0663 and Gout

ArticleYear
Comparative efficacy of traditional non-selective NSAIDs and selective cyclo-oxygenase-2 inhibitors in patients with acute gout: a systematic review and meta-analysis.
    BMJ open, 2020, 09-10, Volume: 10, Issue:9

    Topics: Anti-Inflammatory Agents, Non-Steroidal; China; Diclofenac; Etoricoxib; Gout; Humans

2020
Efficacy and safety of etoricoxib compared with NSAIDs in acute gout: a systematic review and a meta-analysis.
    Clinical rheumatology, 2016, Volume: 35, Issue:1

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 2 Inhibitors; Diclofenac; Etoricoxib; Gout; Humans; Indomethacin; Pain Measurement; Pyridines; Randomized Controlled Trials as Topic; Sulfones; Treatment Outcome

2016
Etoricoxib.
    Drugs, 2002, Volume: 62, Issue:18

    Topics: Administration, Oral; Arthritis; Back Pain; Clinical Trials as Topic; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Gout; Humans; Isoenzymes; Membrane Proteins; Oral Surgical Procedures; Pain, Postoperative; Prostaglandin-Endoperoxide Synthases; Pyridines; Sulfones

2002
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
    MMW Fortschritte der Medizin, 2005, Aug-04, Volume: 147, Issue:31-32

    Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Celecoxib; Controlled Clinical Trials as Topic; Cyclooxygenase Inhibitors; Etoricoxib; Gout; Humans; Osteoarthritis; Placebos; Pyrazoles; Pyridines; Rheumatic Diseases; Spondylitis, Ankylosing; Sulfonamides; Sulfones

2005

Trials

4 trial(s) available for mk 0663 and Gout

ArticleYear
Combination Therapies of Diacerein and Febuxostat Inhibit IL-1β Responses and Improve Clinical Symptoms in Patients With Refractory Gout.
    American journal of therapeutics, 2017, Volume: 24, Issue:3

    Topics: Adult; Anthraquinones; Anti-Inflammatory Agents; C-Reactive Protein; Case-Control Studies; Drug Therapy, Combination; Etoricoxib; Febuxostat; Female; Follow-Up Studies; Gout; Gout Suppressants; Humans; Interleukin-18; Interleukin-1beta; Male; Middle Aged; Prospective Studies; Pyridines; Sulfones; Treatment Outcome; Uric Acid

2017
Serum urate during acute gout.
    The Journal of rheumatology, 2009, Volume: 36, Issue:6

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Cyclooxygenase Inhibitors; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pyridines; Sulfones; Treatment Outcome; Uric Acid; Young Adult

2009
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:2

    Topics: Administration, Oral; Double-Blind Method; Drug Administration Schedule; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pain; Pain Measurement; Pyridines; Sulfones; Treatment Outcome

2004
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout.
    Current medical research and opinion, 2007, Volume: 23, Issue:7

    Topics: Acute Disease; Adult; Arthralgia; Arthritis; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Resistance; Etoricoxib; Female; Gout; Gout Suppressants; Humans; Indomethacin; Male; Middle Aged; Pyridines; Sulfones

2007

Other Studies

1 other study(ies) available for mk 0663 and Gout

ArticleYear
[Rapidly acting and powerful antirheumatic drug now also approved in Germany. Arcoxia (etoricoxib, MSD)]].
    Krankenpflege Journal, 2004, Volume: 42, Issue:7-10

    Topics: Acute Disease; Antirheumatic Agents; Arthralgia; Arthritis, Rheumatoid; Clinical Trials as Topic; Drug Approval; Etoricoxib; Gout; Humans; Indomethacin; Osteoarthritis; Pain Measurement; Pyridines; Sulfones

2004